Project Oncology®

192 Épisodes

1. Highlighting the Current Status and Future of Theranostics

   Publié: 28/06/2024
2. The Evolving AI Landscape in Nuclear Medicine

   Publié: 28/06/2024
3. MCED Testing: Strategies for Mitigating the Risk of Overdiagnosis

   Publié: 20/06/2024
4. A Look at the Horizon of Cancer Vaccines

   Publié: 20/06/2024
5. A Unique Look at the Current and Future Directions of Cancer Vaccines

   Publié: 20/06/2024
6. Updates on New Technologies and Imaging Agents in Healthcare

   Publié: 14/06/2024
7. The Power of Patient Advocacy in Daily Clinical Practice

   Publié: 14/06/2024
8. The Impact of Advocacy on Healthcare

   Publié: 14/06/2024
9. Practical Applications for Quality Improvement in Myelofibrosis Management: A Video Brief on Lessons Learned

   Publié: 12/06/2024
10. A Pre-Conference Perspective of SNMMI 2024

    Publié: 06/06/2024
11. An Introduction to Squamous Cell Carcinoma of the Head and Neck

    Publié: 06/06/2024
12. EMERALD Trial: An Analysis of Key Biomarkers and Patient Subgroups

    Publié: 31/05/2024
13. Poster Pearl: A 2-Biomarker Class MCED Test Delivers High Specificity and Sensitivity

    Publié: 23/05/2024
14. Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer

    Publié: 09/05/2024
15. Optimizing First-Line Immunotherapy for Recurrent or Metastatic HNSCC

    Publié: 03/05/2024
16. Managing Immune-Related Adverse Events With Immunotherapies

    Publié: 03/05/2024
17. Current and Emerging Biomarkers of Response to Immunotherapeutic Regimens

    Publié: 03/05/2024
18. The Role of Immunotherapy in the Treatment of Recurrent or Metastatic HNSCC: The Evidence

    Publié: 03/05/2024
19. Overcoming Barriers to Equitable Care in HNSCC

    Publié: 03/05/2024
20. Indications to Switch Therapies for Myelofibrosis Patients

    Publié: 23/04/2024